Stock ACLX ARCELLX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Arcellx, Inc.

Equities

ACLX

US03940C1009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
53.62 USD +1.57% Intraday chart for Arcellx, Inc. +1.69% -3.39%
May. 15 Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating MT
May. 14 Evercore ISI Starts Arcellx With Outperform Rating MT

Evolution of the average Target Price on Arcellx, Inc.

Price target over the last 5 years

History of analyst recommendation changes

df9c54a44d85439f9a1a2775fa93.-4CkTXxYotZUA4d3gCJrHtq68t62YUtvfygwMdQaMYA.1svJCygX8YxnecYx1U8yeZv3tLTGPjM5Ok5aW-1dRPOZ2JMsFAv6smBrsw~a7fdde50a51c6923493130af455a9e32

Analyst Recommendations on Arcellx, Inc.

Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating MT
Evercore ISI Starts Arcellx With Outperform Rating MT
Arcellx Insider Sold Shares Worth $932,557, According to a Recent SEC Filing MT
Arcellx Insider Sold Shares Worth $522,260, According to a Recent SEC Filing MT
Arcellx Insider Sold Shares Worth $1,548,887, According to a Recent SEC Filing MT
Arcellx Insider Sold Shares Worth $35,575,755, According to a Recent SEC Filing MT
Needham Raises Arcellx Price Target to $81 From $72, Maintains Buy Rating MT
Morgan Stanley Initiates Arcellx With Overweight Rating, $81 Price Target MT
Truist Adjusts Price Target on Arcellx to $87 From $57, Maintains Buy Rating MT
Barclays Adjusts Arcellx's Price Target to $73 From $62, Keeps Overweight Rating MT
Scotiabank Starts Arcellx With Sector Outperform Rating, $66 Price Target MT
Needham Adjusts Price Target on Arcellx to $65 From $60, Keeps Buy Rating MT
Arcellx Phase 1 Expansion Study Data for Cancer Candidate Shows 100% Overall Response Rate MT
HC Wainwright Raises Arcellx's Price Target to $60 From $50, Keeps Buy Rating MT
Needham Raises Arcellx Price Target to $60 From $51, Maintains Buy Rating MT
TD Cowen Starts Arcellx at Outperform MT
UBS Initiates Coverage on Arcellx With Buy Rating, $52 Price Target MT
Stifel Trims Price Target on Arcellx to $52 From $54, Maintains Buy Rating MT
Baird Adjusts Price Target on Arcellx to $52 From $40, Maintains Outperform Rating MT
Needham Reinstates Buy Rating on Arcellx With $51 Price Target MT
HC Wainwright Adjusts Arcellx's Price Target to $50 From $49, Keeps Buy Rating MT
Truist Securities Trims Price Target on Arcellx to $57 From $60, Maintains Buy Rating MT
Small Rate Cut in China Weighs on Wall Street Pre-Bell; Asia Mixed, Europe Off MT
Truist Securities Starts Arcellx at Buy With $60 Price Target MT
BofA Securities Adjusts Arcellx's Price Target to $50 From $39, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
53.62 USD
Average target price
80.57 USD
Spread / Average Target
+50.26%
High Price Target
87 USD
Spread / Highest target
+62.25%
Low Price Target
73 USD
Spread / Lowest Target
+36.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Arcellx, Inc.

Stifel Nicolaus
Evercore ISI
Needham & Co.
Morgan Stanley
Truist Securities
Barclays
Scotiabank
HC Wainwright
TD Cowen
UBS
Baird
BofA Securities
Canaccord Genuity
Guggenheim
SVB Securities LLC
SVB Leerink
William Blair & Co.

Ratings for Arcellx, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ACLX Stock
  4. Consensus Arcellx, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW